Form 4: Amneal Pharmaceuticals Executive Vice President Reports Stock Transactions
SEC Form 4 Filing
Nikita Shah, Executive Vice President of Amneal Pharmaceuticals, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- Nikita Shah, an Executive Vice President at Amneal Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- On March 1, 2025, Ms. Shah had 28,958 restricted stock units vest, which converted into Class A Common Stock.
- A portion of the shares (10,985) were withheld to satisfy tax obligations at a price of $8.67 per share.
- Following these transactions, Ms. Shah directly owns 309,639 shares of Class A Common Stock.
- The restricted stock units were granted on March 1, 2021, and vest in four equal installments annually.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment. It reflects standard compensation practices and does not inherently suggest positive or negative implications for the company's performance.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the vesting of previously granted equity compensation.
- Employees who receive stock-based compensation are directly impacted by the vesting of restricted stock units.
Key Dates
| Date | Description |
|---|---|
| 03/01/2021 | Date of grant of 115,830 restricted stock units, vesting in four equal payments beginning on the first anniversary of the grant date. |
| 03/01/2025 | Date of transaction: Vesting of 28,958 restricted stock units and withholding of 10,985 shares for tax obligations. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.